Category: 6th Symposium

A Biopsychosocial Approach to HIV-Associated Neurocognitive Disorders.

Current Situation of Neuropsychological Problems of HIV Patients in Europe: Role of the European AIDS Clinical Society (EACS).

Prevalence and clinical management of the neurocognitive disorders in the HIV-infected population.

Incidence, Risk Factors and Neurocognitive Impact of CSF Viral Escape: Longitudinal Analysis of the CHARTER & HNRP Cohorts.

Pilot study: Cognitive functioning evaluation in Spanish vertically HIV-infected children and adolescents.

Cognitive Rehabilitation Protocol in HIV/AIDS Outpatients with ANI and MND: a pilot study.

Cognitive Complaints in People with HIV in Spain: Prevalence and Related Variables.

Neuropsychological performance in acute HIV: determinants of baseline performance and effects of immediate antiretroviral therapy

Switch from Efavirenz for CNS toxicity-UK experience.

Comparative Neuropsychiatric Profile of Dolutegravir and Efavirenz after 48w in treatment naïve patients: Data from ING114467 SINGLE study.